That GLP-1part of a class of drugs (called glucagon-like peptides) originally designed to treat diabetes that found huge success in aiding weight lossstarted a biochemical stampede that has impacted the treatment of serious diseases and multiple industries (beauty, sexual wellness, brain health, and fitness, to name a few) and made regular people feel okay about routinely injecting a drug into their bodies
Theyre usually kind
Higher doses of semaglutide may lead to quicker or more pronounced appetite suppression, but they can also increase the risk of side effects
Semaglutide Semaglutide (GLP-1 receptor agonist) research peptide high-purity lyophilized powder, third-party tested with a Certificate of Analysis on every batch
22.5% PBO-adjusted weight loss at 48 weeks, comparable to retatrutide and ahead of tirzepatide's SURMOUNT-1
However, MK-677s side effect management (glucose monitoring, appetite control, potential lethargy interventions) adds hidden costs
